Results 231 to 240 of about 304,363 (385)

Drug Repositioning of Pegbing® for Essential Thrombocythemia: Insights from PK/PD Modeling and Extrapolation

Clinical Pharmacology &Therapeutics, EarlyView.
Pegbing® (peginterferon alfa‐2b), a pegylated interferon‐alpha, is approved for the treatment of chronic hepatitis B (CHB) and C. One of its adverse effects is platelet (PLT) suppression. It is currently being repurposed for the treatment of essential thrombocythemia (ET), a rare myeloproliferative disorder characterized by abnormally elevated PLT ...
Weizhe Jian, Yalin Yin, Rong Chen, Junsheng Xue, Jianbo Gu, Zhengfang Du, Ruoyi He, Tianyan Zhou   +7 more
wiley   +1 more source

Promoter Specificity and Transcription Levels Modulate <i>Trans</i>-Splicing Efficiency at the <i>mod</i>(<i>mdg4</i>) Locus in <i>Drosophila</i>. [PDF]

Int J Mol Sci
Beginyazova O, Soldatova IV, Georgiev P, Tikhonov M.   +3 more
europepmc   +1 more source

Control of mRNA Stability in Fungi by NMD, EJC and CBC Factors Through 3′UTR Introns [PDF]

, 2015
Ying Zhang, Matthew S. Sachs
openalex   +1 more source

Pathway‐Informed Machine Learning Identifies Genetic Predictors of High‐Dose Methotrexate‐Induced Mucositis in Pediatric Acute Lymphoblastic Leukemia

Clinical Pharmacology &Therapeutics, EarlyView.
High‐dose methotrexate for pediatric cancer treatment is frequently associated with mucositis, which can lead to delayed or discontinued treatment and impact survival. While individual genetic variants have been implicated, the cumulative impact of genetic variation within relevant biological pathways remains unexplored.
Xiao Yu Cindy Zhang, Erika N. Scott, Hedy Maagdenberg, Alice Man, Kathy H. Li, S. Rod Rassekh, Bruce C. Carleton, Colin J. D. Ross, Wyeth W. Wasserman, Catrina M. Loucks   +9 more
wiley   +1 more source

Systematic mapping of small nucleolar RNA interactions in human cells. [PDF]

RNA Biol
Dunn-Davies H, Dudnakova T, Langhendries JL, Watkins N, Lafontaine DLJ, Tollervey D.   +5 more
europepmc   +1 more source

Three different group I introns in the nuclear large subunit ribosomal DNA of the amoeboflagellate Naegleria

, 1998
Johan F. De Jonckheere, S. Brown
openalex   +2 more sources

Spread of the group II intron RmInt1 and its insertion sequence target sites in the plant endosymbiontSinorhizobium meliloti [PDF]

, 2011
Emanuele G. Biondi, Nicolás Toro, Marco Bazzicalupo, Francisco Martı́nez-Abarca   +3 more
openalex   +1 more source

Navigating the Genetic Risk of Chemotherapy‐Induced Hearing Loss in the Stria Vascularis

Clinical Pharmacology &Therapeutics, EarlyView.
Cisplatin is a chemotherapy drug that causes permanent hearing loss by damaging a critical tissue lining the inner ear, called the stria vascularis (SV). Currently, the molecular mechanisms of SV damage are largely unknown and the incidence of ototoxicity in patients cannot be reliably predicted.
Tara Lazetic, Deanne Nixie R. Miao, Britt I. Drögemöller, Alain Dabdoub, Julia M. Abitbol   +4 more
wiley   +1 more source

Exploring a crossroads in the aging process. [PDF]

Elife
Shabestary K, Gottschling DE.
europepmc   +1 more source

Improvement of EPO Transgene Detection From Polymeric Dried Blood Spots for Antidoping Application

Drug Testing and Analysis, EarlyView.
This article presents an optimized protocol for gene doping detection. Starting from one spot DBS (20 μL), concentrated DNA was obtained and real‐time PCR parameters were adjusted for increased detection. Robust detection of 5000 copies/mL of transgene was validated for polymeric device TASSO M‐20.
Alexandre Marchand, Ingrid Roulland, Magnus Ericsson   +2 more
wiley   +1 more source